About this trial
What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?
Eligibility criteria
Qualifiers
Age 3 to 60 years.
Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications.
Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery.
Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required.
Disqualifiers
Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation.
History of any previous neurosurgical craniotomy before epilepsy surgery.
Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up.
Contraindication to surgery.
Trial design
Treatments tested in this trial
- Using High-density Flexible microElectrocorticography for intraoperative monitoring
Treatment groups
Sponsors and collaborators
Beijing Tiantan Hospital
Lead sponsor
Beijing Neurosurgical Institute
Sponsor institution
Beijing Fengtai Hospital
Collaborator
Peking University First Hospital
Collaborator
The Chinese University of Hong Kong, Shenzhen
Collaborator
Beijing Xinzhida Neural Technology Co., Ltd
Collaborator
Beijing Neurosurgical Institute
Collaborator